Analytical measurement of PEGylated molecules

Area of Science:

• Pharmaceutical Sciences
• Bioconjugation Chemistry

Background:

• Poly(ethylene glycol) (PEG) conjugation improves drug pharmacokinetics and efficacy.
• PEGylated pharmaceuticals have seen increasing clinical use since 1990.
• Accurate analysis of PEG conjugates in biological fluids is crucial for drug development.

Purpose of the Study:

• To review analytical methods for detecting and quantifying PEGylated pharmaceuticals in biological samples.
• To provide insights into assays for pharmacokinetic and biodistribution studies of PEGylated molecules.

Main Methods:

• Review of colorimetric assays.
• Review of chromatographic methods (e.g., HPLC, UPLC).
• Review of radiolabeled assays.
• Review of biological assays.
• Review of enzyme-linked immunosorbent assays (ELISA).

Main Results:

• Various assay methods are available for PEGylated pharmaceutical analysis.
• These methods enable the determination of biodistribution and pharmacokinetic properties.
• Selection of appropriate assays depends on the specific PEGylated molecule and biological matrix.

Conclusions:

• Accurate analytical methods are essential for the successful clinical development of PEGylated drugs.
• The reviewed assays support the pharmacokinetic and biodistribution assessment of PEGylated pharmaceuticals.
• This review provides a guide to selecting suitable methods for analyzing PEG conjugates in complex biological samples.